Palatin Technologies (STU:PTN) Other Financing : €0.12 Mil (TTM As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Palatin Technologies Other Financing?

Palatin Technologies's Other Financing for the three months ended in Mar. 2024 was €0.00 Mil.

Palatin Technologies's Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 was €0.12 Mil.

Palatin Technologies Other Financing Historical Data

The historical data trend for Palatin Technologies's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palatin Technologies Other Financing Chart

Palatin Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Financing

Get a 7-Day Free Trial

0.61

-2.37

0.07

-0.14

Palatin Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Financing	Get a 7-Day Free Trial															-	0.17	-0.05	-	-

Palatin Technologies Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.12 Mil.

Palatin Technologies Other Financing Related Terms

Thank you for viewing the detailed overview of Palatin Technologies's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Palatin Technologies (STU:PTN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palatin Technologies Inc (STU:PTN) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

PTN:USA PTN:Germany

Address

4B Cedar Brook Drive, Cranbury, NJ, USA, 08512

Website

https://www.palatin.com

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.